Sanuwave Health Inc. (SNWV) Beats Q3 Earnings and Revenue Estimates

Core Viewpoint - Sanuwave Health Inc. reported quarterly earnings of $0.46 per share, exceeding the Zacks Consensus Estimate of $0.32 per share, and showing a significant improvement from a loss of $6.49 per share a year ago [1] Financial Performance - The company achieved revenues of $11.45 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.18%, and up from $9.36 million in the same quarter last year [2] - Over the last four quarters, Sanuwave Health has exceeded consensus EPS estimates two times and topped consensus revenue estimates twice [2] Stock Performance - Sanuwave Health shares have increased approximately 14.8% since the beginning of the year, compared to a 14.3% gain in the S&P 500 [3] Future Outlook - The company's earnings outlook will be crucial for investors, with current consensus EPS estimates at $0.20 for the coming quarter and $0.34 for the current fiscal year, alongside projected revenues of $13.5 million and $44.44 million respectively [7] - The estimate revisions trend for Sanuwave Health was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Medical - Products industry, to which Sanuwave Health belongs, is currently ranked in the bottom 35% of over 250 Zacks industries, suggesting potential challenges ahead [8]